Practical sheet | REF: FIC1175 V1

Systemic toxicity: kidneys, primary target organs

Author: Alain LOMBARD

Publication date: May 10, 2025 | Lire en français

You do not have access to this resource.
Click here to request your free trial access!

Already subscribed? Log in!


7. Frequently asked questions

How can I check the information in the MSDS?

The information is contained in chapter 11 – Toxicology in the paragraphs "Specific Target Organ Toxicity" or STOT.

How can information contained in the SDS be verified in the REACh dossier?

The detailed description of toxicology studies includes the results of biochemical and histological analyses, for example in the carcinogenesis study on methylene chloride: inhalation doses in three groups: 0, 2,000 and 4,000 ppm.

Kidneys: the incidence of morphological changes in renal tubules is increased between control and test animals: in male mice: control (6/50, 12%), low dose (11/49, 22%), high dose (20/50, 40%) in female mice: control (8/49, 16%); low dose (23/48, 48%); high dose (23/47, 49%).

You do not have access to this resource.

Exclusive to subscribers. 97% yet to be discovered!

You do not have access to this resource.
Click here to request your free trial access!

Already subscribed? Log in!


The Ultimate Scientific and Technical Reference

A Comprehensive Knowledge Base, with over 1,200 authors and 100 scientific advisors
+ More than 10,000 articles and 1,000 how-to sheets, over 800 new or updated articles every year
From design to prototyping, right through to industrialization, the reference for securing the development of your industrial projects

This article is included in

Safety and risk management

This offer includes:

Knowledge Base

Updated and enriched with articles validated by our scientific committees

Services

A set of exclusive tools to complement the resources

Practical Path

Operational and didactic, to guarantee the acquisition of transversal skills

Doc & Quiz

Interactive articles with quizzes, for constructive reading

Subscribe now!

Ongoing reading
Frequently asked questions